Cite
HARVARD Citation
Hughes, R. et al. (2018). Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. Lancet neurology. 17 (8), pp. 689-698. [Online].